跳至主要内容
临床试验/NCT05622357
NCT05622357已完成2 期

Prospective Phase II Study of Hypofractionated Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2018年3月18日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
51
试验地点
1
主要终点
pathological complete response (pCR)

研究概览

简要总结

The goal of this clinical trial is to investigate total neoadjuvant therapy (TNT) using short course radiation therapy (SCRT) followed by full course of chemotherapy then surgery in locally advanced rectal cancer. The main questions it aims to answer are:

  • Is total neoadjuvant treatment in this design safe & tolerable?
  • Impact of this design on treatment related outcomes in terms of pathological and clinical responses.

详细描述

Patients will be assigned to an experimental arm in which preoperative short course 5 x 5 Gy radiation therapy is followed by six cycles of combination chemotherapy (capecitabine and oxaliplatin) and surgery within 4-6 weeks

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Histopathological proof of rectal adenocarcinoma.
  • •Tumors located within 15 cm and not less than 4 cm from anal verge.
  • •Age: ≥ 18 years.
  • •Locally advanced resectable rectal cancer (cT3/4 N0- Any T N+ve).
  • •ECOG Performance Status: 0-2.

排除标准

  • •Non-epithelial rectal malignancy such as sarcoma or lymphoma.
  • •Unresectable tumors in which surgery will never be possible even if substantial tumor downsizing is seen.
  • •Recurrent rectal cancer.
  • •Previous history of malignancy within the last 5 years.
  • •Previous pelvic irradiation.
  • •Psychiatric or addictive disorder that would preclude study therapy.
  • •Concurrent uncontrolled medical conditions.
  • •Pregnancy or breast feeding.
  • •Any contraindication to surgery.
  • •Extensive peripheral neuropathy.

研究组 & 干预措施

Short course RT followed by full course of chemotherapy then surgery

Experimental

Short course radiation therapy ( 25 Gy/ 5 fractions/ 1 week) , followed by 6 cycles of chemotherapy CAPOX, followed 4-6 weeks by surgery.

干预措施: short course radiation therapy followed by 6 cycles of CAPOX then surgery (Radiation)

结局指标

主要结局

pathological complete response (pCR)

时间窗: within 30 days

No residual disease in surgical specimen

clinical complete response(cCR)

时间窗: within 30 days

No residual disease after end of radiation and chemotherapy by examination,imaging and colonoscopy

Sphincter saving surgery

时间窗: within 6 months

Patients who were deemed abdomino-perineal resection before treatment start \& were able to undergo low anterior resection after end of treatment

次要结局

  • Local control(3 years)
  • Overall survival(3 years)
  • Disease free survival(within 3 years)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yasser Anwar

Lecturer of Radiation Oncology

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验

Prospective Study of Short Course Radiation Therapy... | 临床试验